CEE-03320

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameCEE-03320
Drug Alias NameNNC-220215CEE-03-320CEE-320
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor antagonists
TargetsDopamine D1 receptor
Therapy Area/IndicationsSchizophreniaSubstance-Related DisordersSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeNeS Pharmaceuticals plc
Active IndicationsN/A
Inactive IndicationsSchizophreniaSubstance-Related DisordersSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksN/A